Cipralex is licenced for the treatment of major depressive disorder (MDD), generalised anxiety disorder (GAD), social anxiety disorder (SAD), panic disorder (PD) and obsessive compulsive disorder (OCD)
A large collection of studies have been carried out to assess the efficacy and safety of Cipralex across its licenced indications. To learn more, please select which disease area you wish to review: